• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS Back to Search Results
Catalog Number 07C18-41
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/22/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 7c18 that has a similar product distributed in the us, list number 1l82.
 
Event Description
The customer reported a false positive architect (b)(6) result on a (b)(6) yr old male patient.Results provided: (b)(6) = 40 miu/ml, (b)(6) = > 250 iu/ml, (b)(6) = 12.6 s/co; immunochromatography: (b)(6) = positive, (b)(6) = negative.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint investigation for potential false reactive anti-hbs results included a search for similar complaints, and review of complaint text, trending data, labeling, and device history records.In-house testing of reagent lot 06510fn00 was completed.Return testing was not completed as returns were not available.Trending review determined no trends for the issue for the product.Device history record review on lot 06510fn00 did not show any potential non-conformances, or deviations.Labeling was reviewed and found to adequately address the issue under review.In house testing of controls which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.Based on the investigation, no systemic issue or deficiency of the architect anti-hbs assay, lot number 06510fn00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS
Type of Device
ANTI-HBS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key10263750
MDR Text Key230623527
Report Number3008344661-2020-00057
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 08/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/24/2020
Device Catalogue Number07C18-41
Device Lot Number06510FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/22/2020
Initial Date FDA Received07/13/2020
Supplement Dates Manufacturer Received08/19/2020
Supplement Dates FDA Received08/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER LIST 03M74-01; SERIAL (B)(6).
Patient Age52 YR
-
-